Cargando…

Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava

BACKGROUND: Persistent left superior vena cava (PLSVC) is the most common venous system variant. The clinical characteristics and amniotic fluid cytogenetics of fetuses with PLSVC remain to be further explored. AIM: To develop reliable prenatal diagnostic recommendations through integrated analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xin, Su, Xin-Hui, Zeng, Zhen, Fan, Yao, Wu, Yuan, Guo, Li-Li, Xu, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600788/
https://www.ncbi.nlm.nih.gov/pubmed/37900905
http://dx.doi.org/10.4330/wjc.v15.i10.500
_version_ 1785126062582136832
author Yang, Xin
Su, Xin-Hui
Zeng, Zhen
Fan, Yao
Wu, Yuan
Guo, Li-Li
Xu, Xiao-Yan
author_facet Yang, Xin
Su, Xin-Hui
Zeng, Zhen
Fan, Yao
Wu, Yuan
Guo, Li-Li
Xu, Xiao-Yan
author_sort Yang, Xin
collection PubMed
description BACKGROUND: Persistent left superior vena cava (PLSVC) is the most common venous system variant. The clinical characteristics and amniotic fluid cytogenetics of fetuses with PLSVC remain to be further explored. AIM: To develop reliable prenatal diagnostic recommendations through integrated analysis of the clinical characteristics of fetuses with PLSVC. METHODS: Cases of PLSVC diagnosed using prenatal ultrasonography between September 2019 and November 2022 were retrospectively studied. The clinical characteristics of the pregnant women, ultrasonic imaging information, gestational age at diagnosis, pregnancy outcomes, and amniocentesis results were summarized and analyzed using categorical statistics and the chi-square test or Fisher’s exact test. RESULTS: Of the 97 cases diagnosed by prenatal ultrasound, 49 (50.5%) had isolated PLSVC and 48 (49.5%) had other structural abnormalities. The differences in pregnancy outcomes and amniocentesis conditions between the two groups were statistically significant (P < 0.05). No significant differences were identified between the two groups in terms of advanced maternal age and gestational age (P > 0.05). According to the results of the classification statistics, the most common intracardiac abnormality was a ventricular septal defect and the most common extracardiac abnormality was a single umbilical artery. In the subgroup analysis, the concurrent combination of intra- and extracardiac structural abnormalities was a risk factor for adverse pregnancy outcomes (odds ratio > 1, P < 0.05). Additionally, all abnormal cytogenetic findings on amniocentesis were observed in the comorbidity group. One case was diagnosed with 21-trisomy and six cases was diagnosed with chromosome segment duplication. CONCLUSION: Examination for other structural abnormalities is strongly recommended when PLSVC is diagnosed. Poorer pregnancy outcomes and increased amniocentesis were observed in PLSVC cases with other structural abnormalities. Amniotic fluid cytogenetics of fetuses is recommended for PLSVC with other structural abnormalities.
format Online
Article
Text
id pubmed-10600788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-106007882023-10-27 Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava Yang, Xin Su, Xin-Hui Zeng, Zhen Fan, Yao Wu, Yuan Guo, Li-Li Xu, Xiao-Yan World J Cardiol Retrospective Study BACKGROUND: Persistent left superior vena cava (PLSVC) is the most common venous system variant. The clinical characteristics and amniotic fluid cytogenetics of fetuses with PLSVC remain to be further explored. AIM: To develop reliable prenatal diagnostic recommendations through integrated analysis of the clinical characteristics of fetuses with PLSVC. METHODS: Cases of PLSVC diagnosed using prenatal ultrasonography between September 2019 and November 2022 were retrospectively studied. The clinical characteristics of the pregnant women, ultrasonic imaging information, gestational age at diagnosis, pregnancy outcomes, and amniocentesis results were summarized and analyzed using categorical statistics and the chi-square test or Fisher’s exact test. RESULTS: Of the 97 cases diagnosed by prenatal ultrasound, 49 (50.5%) had isolated PLSVC and 48 (49.5%) had other structural abnormalities. The differences in pregnancy outcomes and amniocentesis conditions between the two groups were statistically significant (P < 0.05). No significant differences were identified between the two groups in terms of advanced maternal age and gestational age (P > 0.05). According to the results of the classification statistics, the most common intracardiac abnormality was a ventricular septal defect and the most common extracardiac abnormality was a single umbilical artery. In the subgroup analysis, the concurrent combination of intra- and extracardiac structural abnormalities was a risk factor for adverse pregnancy outcomes (odds ratio > 1, P < 0.05). Additionally, all abnormal cytogenetic findings on amniocentesis were observed in the comorbidity group. One case was diagnosed with 21-trisomy and six cases was diagnosed with chromosome segment duplication. CONCLUSION: Examination for other structural abnormalities is strongly recommended when PLSVC is diagnosed. Poorer pregnancy outcomes and increased amniocentesis were observed in PLSVC cases with other structural abnormalities. Amniotic fluid cytogenetics of fetuses is recommended for PLSVC with other structural abnormalities. Baishideng Publishing Group Inc 2023-10-26 2023-10-26 /pmc/articles/PMC10600788/ /pubmed/37900905 http://dx.doi.org/10.4330/wjc.v15.i10.500 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Study
Yang, Xin
Su, Xin-Hui
Zeng, Zhen
Fan, Yao
Wu, Yuan
Guo, Li-Li
Xu, Xiao-Yan
Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
title Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
title_full Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
title_fullStr Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
title_full_unstemmed Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
title_short Integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
title_sort integrated analysis of comorbidity, pregnant outcomes, and amniotic fluid cytogenetics of fetuses with persistent left superior vena cava
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600788/
https://www.ncbi.nlm.nih.gov/pubmed/37900905
http://dx.doi.org/10.4330/wjc.v15.i10.500
work_keys_str_mv AT yangxin integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava
AT suxinhui integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava
AT zengzhen integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava
AT fanyao integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava
AT wuyuan integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava
AT guolili integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava
AT xuxiaoyan integratedanalysisofcomorbiditypregnantoutcomesandamnioticfluidcytogeneticsoffetuseswithpersistentleftsuperiorvenacava